312 related articles for article (PubMed ID: 17269692)
1. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
[TBL] [Abstract][Full Text] [Related]
2. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
3. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
Kim BJ; Chang HN; Oh DJ
Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
[TBL] [Abstract][Full Text] [Related]
4. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
5. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
[TBL] [Abstract][Full Text] [Related]
6. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
7. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
[TBL] [Abstract][Full Text] [Related]
8. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
Tey BT; Al-Rubeai M
Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
[TBL] [Abstract][Full Text] [Related]
9. Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture.
Yang JD; Lu C; Stasny B; Henley J; Guinto W; Gonzalez C; Gleason J; Fung M; Collopy B; Benjamino M; Gangi J; Hanson M; Ille E
Biotechnol Bioeng; 2007 Sep; 98(1):141-54. PubMed ID: 17657776
[TBL] [Abstract][Full Text] [Related]
10. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
11. Continuous production of monoclonal antibody in a packed-bed bioreactor.
Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
[TBL] [Abstract][Full Text] [Related]
12. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
Dong H; Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
[TBL] [Abstract][Full Text] [Related]
13. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
[TBL] [Abstract][Full Text] [Related]
14. Inclined sedimentation for selective retention of viable hybridomas in a continuous suspension bioreactor.
Batt BC; Davis RH; Kompala DS
Biotechnol Prog; 1990; 6(6):458-64. PubMed ID: 1366836
[TBL] [Abstract][Full Text] [Related]
15. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
Gramer MJ; Maas J
Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
[TBL] [Abstract][Full Text] [Related]
16. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
[TBL] [Abstract][Full Text] [Related]
17. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
Frahm B; Lane P; Märkl H; Pörtner R
Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
[TBL] [Abstract][Full Text] [Related]
18. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
[TBL] [Abstract][Full Text] [Related]
19. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
Krampe B; Swiderek H; Al-Rubeai M
Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
